SCHEMBL22275940

SCHEMBL22275940

Cc1ccc(OC(C)C)cc1-c1nn(C)c2ncnc(N)c12

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SRC P12931 14/20 0.54
PIK3CD O00329 14/20 0.54
PIK3CA P42336 14/20 0.54
PIK3CB P42338 14/20 0.54
PIK3CG P48736 14/20 0.54
PRKDC P78527 14/20 0.54
ABL1 P00519 12/20 0.54
HCK P08631 12/20 0.54
EGFR P00533 11/20 0.54
MTOR P42345 11/20 0.54
EPHB4 P54760 11/20 0.54
KDR P35968 10/20 0.54
PI4KB Q9UBF8 5/20 0.54
NUDT14 O95848 1/20 0.51
NUDT5 Q9UKK9 1/20 0.51
RET P07949 1/20 0.43
AURKA O14965 1/20 0.42
IKBKE Q14164 1/20 0.42
AURKB Q96GD4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL129575 0.88 SRC (0.53) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130644 0.82 NUDT14 (0.70) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL128513 0.81 PIK3CD (0.67) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL13828353 0.77 SRC (0.63) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL129875 0.74 FGFR1 (0.55) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130513 0.73 SRC (0.79) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23917240 0.72 PIK3CD (0.78) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL130467 0.72 PIK3CD (0.61) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL129863 0.72 SRC (0.61) SRCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL17970673 0.70 PIK3CD (0.65) SRCPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239427-A1 NOVEL KINASE MODULATORS RHIZEN PHARMACEUTICALS AG (CH) 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239427-A1 NOVEL KINASE MODULATORS PRKCA, PRKCH, PRKCB SRC 314/4885PIK3CD 70/4885PIK3CA 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.